Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Keating

Showing results (11-20 of 341) with videos related to

Pageof 35
Sort By:
Cancer|December 4, 2004
Richter syndrome: biology, incidence, and therapeutic strategiesApostolia-Maria Tsimberidou, Michael J Keating
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Expert Review of Anticancer Therapy|October 6, 2006
Monoclonal antibodies in chronic lymphocytic leukemiaAlessandra Ferrajoli, Stefan Faderl, Michael J Keating
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Current Hematologic Malignancy Reports|April 29, 2010
New aspects of the treatment of chronic lymphocytic leukemiaStefan Faderl, William Wierda, Michael J Keating
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Critical Reviews in Oncology/Hematology|August 15, 2013
Targeting inflammatory pathways in chronic lymphocytic leukemiaUri Rozovski, Michael J Keating, Zeev Estrov
Acta Haematologica|August 17, 2018
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?Uri Rozovski, Michael J Keating, Zeev Estrov
Molecular Cancer Therapeutics|December 7, 2002
UCN-01 (7-hydroxystaurosporine) inhibits DNA repair and increases cytotoxicity in normal lymphocytes and chronic lymphocytic leukemia lymphocytesTakahiro Yamauchi, Michael J Keating, William Plunkett
Pageof 35

Showing results (11-20 of 341) with videos related to

Sort By:
Pageof 35
Cancer|December 4, 2004
Richter syndrome: biology, incidence, and therapeutic strategiesApostolia-Maria Tsimberidou, Michael J Keating
Leukemia & Lymphoma|September 13, 2012
Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?Constantine S Tam, Michael J Keating
Seminars in Oncology|February 1, 2017
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Expert Review of Anticancer Therapy|October 6, 2006
Monoclonal antibodies in chronic lymphocytic leukemiaAlessandra Ferrajoli, Stefan Faderl, Michael J Keating
Seminars in Oncology|February 14, 2002
Emerging information on the use of rituximab in chronic lymphocytic leukemiaMichael J Keating, Susan O'Brien, Maher Albitar
Current Hematologic Malignancy Reports|April 29, 2010
New aspects of the treatment of chronic lymphocytic leukemiaStefan Faderl, William Wierda, Michael J Keating
Best Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J Keating
Critical Reviews in Oncology/Hematology|August 15, 2013
Targeting inflammatory pathways in chronic lymphocytic leukemiaUri Rozovski, Michael J Keating, Zeev Estrov
Acta Haematologica|August 17, 2018
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in Chronic Lymphocytic Leukemia?Uri Rozovski, Michael J Keating, Zeev Estrov
Molecular Cancer Therapeutics|December 7, 2002
UCN-01 (7-hydroxystaurosporine) inhibits DNA repair and increases cytotoxicity in normal lymphocytes and chronic lymphocytic leukemia lymphocytesTakahiro Yamauchi, Michael J Keating, William Plunkett
Pageof 35